Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bifidobacterium longum + Lactobacillus plantarum + Bifidobacterium infantis + Lactobacillus reuteri is a combination of four specific strains of probiotic bacteria. Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. This combination is intended to support gastrointestinal health by modulating the gut microbiota. These bacteria work by colonizing the gut, where they can compete with pathogenic organisms for adhesion sites and nutrients, produce antimicrobial substances, and enhance the integrity of the intestinal barrier. Furthermore, they interact with the host's immune system, particularly the gut-associated lymphoid tissue, to modulate immune responses. Individual strains within this combination have been studied for various benefits; for example, *Bifidobacterium infantis* is noted for its role in the infant gut microbiome and reducing symptoms of Irritable Bowel Syndrome (IBS), *Lactobacillus plantarum* for supporting gut health and immune function, *Bifidobacterium longum* for producing lactic acid and supporting healthy cholesterol levels, and *Lactobacillus reuteri* for preventing infections and treating colic. While products exist that contain some of these strains in combination with others, a commercially available product containing this exact four-strain composition was not explicitly identified in the search results.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bifidobacterium longum + lactobacillus plantarum + bifidobacterium infantis + lactobacillus reuteri.